Article | REF: BIO6810 V1

Therapeutic proteins production in insect cells

Author: Hassan CHAABIHI

Publication date: May 10, 2015

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


Français

6. Technological developments for new applications

6.1 Therapeutic proteins and antibodies

The annual market for therapeutic biomolecules is worth over 145 billion dollars. Recombinant monoclonal antibodies are by far the most representative class of therapeutic biomolecules on this market. In the vast majority of cases, they are produced in CHO cells. Despite their ability to produce perfectly assembled and functional monoclonal antibodies

You do not have access to this resource.

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource.
Click here to request your free trial access!

Already subscribed? Log in!


The Ultimate Scientific and Technical Reference

A Comprehensive Knowledge Base, with over 1,200 authors and 100 scientific advisors
+ More than 10,000 articles and 1,000 how-to sheets, over 800 new or updated articles every year
From design to prototyping, right through to industrialization, the reference for securing the development of your industrial projects

This article is included in

Bioprocesses and bioproductions

This offer includes:

Knowledge Base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

Practical Path

Operational and didactic, to guarantee the acquisition of transversal skills

Doc & Quiz

Interactive articles with quizzes, for constructive reading

Subscribe now!

Ongoing reading
Technological developments for new applications